Darbepoetin alfa (Aranesp TM )i nchildren with chronic renal failure

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients.

  2004cited by this paper
• Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis

  2004cited by this paper
• Treatment of Anemia with Darbepoetin Alfa Administered de novo Once Every Other Week in Chronic Kidney Disease

  2003cited by this paper
• Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease

  2002cited by this paper
• Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.

  2002cited by this paper
• Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

  2002cited by this paper
• Novel erythropoiesis stimulating protein.

  2000cited by this paper
• Detection of anti-erythropoietin antibodies in haemodialysis patients treated with recombinant human-erythropoietin.

  2000cited by this paper
• Erythropoietin treatment in children with renal failure

  1999cited by this paper
• Recombinant human erythropoietin therapy in children on dialysis.

  1996cited by this paper
• Pharmacokinetics of recombinant human erythropoietin in children with renal failure

  1992cited by this paper
• Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.

  1989cited by this paper
• The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

  1987cited by this paper

• Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature

  2018cites this paper